CRIS Current Research Information System

PEA, FEDERICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.819
EU - Europa 5.412
AS - Asia 2.834
AF - Africa 85
SA - Sud America 42
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.212
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.768
IT - Italia 1.801
GB - Regno Unito 1.043
DE - Germania 913
SG - Singapore 870
SE - Svezia 693
CN - Cina 657
IN - India 619
VN - Vietnam 544
IE - Irlanda 273
RU - Federazione Russa 141
FR - Francia 92
UA - Ucraina 76
FI - Finlandia 63
NL - Olanda 52
CH - Svizzera 51
BG - Bulgaria 38
PA - Panama 33
ZA - Sudafrica 28
PL - Polonia 23
ES - Italia 22
TR - Turchia 22
CI - Costa d'Avorio 21
AU - Australia 18
BE - Belgio 18
EE - Estonia 18
HK - Hong Kong 16
CA - Canada 15
HR - Croazia 15
AT - Austria 14
GR - Grecia 13
AR - Argentina 12
JO - Giordania 12
KR - Corea 12
RO - Romania 12
TG - Togo 12
ID - Indonesia 11
JP - Giappone 11
PE - Perù 11
PT - Portogallo 11
CL - Cile 10
NG - Nigeria 10
IL - Israele 9
IR - Iran 9
BR - Brasile 6
PK - Pakistan 6
SC - Seychelles 6
TW - Taiwan 6
UZ - Uzbekistan 6
HU - Ungheria 5
SA - Arabia Saudita 5
SK - Slovacchia (Repubblica Slovacca) 5
CZ - Repubblica Ceca 4
PH - Filippine 4
LB - Libano 3
LI - Liechtenstein 3
UG - Uganda 3
BD - Bangladesh 2
BH - Bahrain 2
CO - Colombia 2
DK - Danimarca 2
EG - Egitto 2
LU - Lussemburgo 2
LV - Lettonia 2
MA - Marocco 2
MK - Macedonia 2
MY - Malesia 2
NO - Norvegia 2
TH - Thailandia 2
A1 - Anonimo 1
BO - Bolivia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
IQ - Iraq 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
OM - Oman 1
RS - Serbia 1
Totale 14.212
Salva come PNG Salva come JPEG
Città #
Southend 952
Fairfield 812
Singapore 746
Ashburn 483
Princeton 476
Woodbridge 411
Dong Ket 354
Seattle 336
Houston 321
Cambridge 296
Wilmington 286
Dublin 273
Bologna 254
Chandler 245
Ann Arbor 182
Milan 166
Santa Clara 161
Des Moines 152
Rome 125
Redwood City 105
Berlin 60
San Diego 60
New York 55
Redmond 51
Beijing 50
Bremen 43
Nanjing 43
Medford 41
Naples 40
Chicago 39
Florence 37
Helsinki 36
Shanghai 36
Bern 35
Turin 34
Sofia 33
Jinan 32
Genoa 29
Saint Petersburg 28
Los Angeles 27
Verona 27
Lappeenranta 26
Paris 26
Mumbai 25
London 24
Padova 24
Guangzhou 23
Vicenza 23
Westminster 23
Jacksonville 22
Modena 22
Bühl 21
Abidjan 20
Istanbul 19
Olalla 19
Tappahannock 19
Forlì 18
Norwalk 16
Shenyang 16
Lecce 15
Frankfurt am Main 14
Hangzhou 14
San Francisco 14
Zhengzhou 14
Boardman 13
Council Bluffs 13
Xi'an 13
Zagreb 13
Amman 12
Amsterdam 12
Bari 12
Changsha 12
Jiaxing 12
Lomé 12
Pescara 12
Shenzhen 12
Warsaw 12
Catania 11
Hyderabad 11
Mülheim 11
Sassari 11
Tianjin 11
Bergamo 10
Brussels 10
Chengdu 10
Fuzhou 10
Lima 10
Shijiazhuang 10
Wuhan 10
Deiva Marina 9
Desio 9
Maranello 9
Melbourne 9
Springfield 9
Torino 9
Venezia 9
Boydton 8
Buenos Aires 8
Catanzaro 8
Dearborn 8
Totale 8.809
Salva come PNG Salva come JPEG
Nome #
A 1 year retrospective audit of quality indicators of clinical pharmacological advice for personalized linezolid dosing: One stone for two birds? 281
An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of infection-related ventilator associated complications (IVACs) caused by Enterobacterales in critically ill adult patients 173
Enhancement of in-vitro activity of ofloxacin and gentamicin by rat serum 150
Acute wound infections management: the ‘Don’ts’ from a multidisciplinary expert panel 135
WSES consensus conference: Guidelines for first-line management of intra-abdominal infections. 133
Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis 126
Antimicrobial Dose Reduction in Continuous Renal Replacement Therapy: Myth or Real Need? A Practical Approach for Guiding Dose Optimization of Novel Antibiotics 125
Could de-escalation of antibiotic therapy be feasible even for documented methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia? 115
What should be the first-choice strategy to maximize posaconazole exposure in daily clinical practice? 114
The current role of glycopeptides in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in not neutropenic adults: the viewpoint of a group of Italian experts 111
A 10-Year Experience of Therapeutic Drug Monitoring (TDM) of Linezolid in a Hospital-wide Population of Patients Receiving Conventional Dosing: Is there Enough Evidence for Suggesting TDM in the Majority of Patients? 108
Levofloxacin dosing regimen in severely morbidly obese patients (BMI ≥40 kg/m2) should be guided by creatinine clearance estimates based on ideal body weight and optimized by therapeutic drug monitoring 108
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia 107
Biliary penetration and pharmacodynamic exposure of linezolid in liver transplant patients 105
Evaluating Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacilli: A Review of the Emerging Data 101
Impact of a newly established expert clinical pharmacological advice program based on TDM results in tailoring antimicrobial therapies hospital-wide in a tertiary university hospital: findings after the first-year of implementation 100
Jumping into the future: overcoming pharmacokinetic/pharmacodynamic hurdles to optimize the treatment of severe difficult to treat-Gram-negative infections with novel beta-lactams 100
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper# 100
Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis. 99
Population pharmacokinetics and Monte Carlo simulation for dosage optimization of fosfomycin in the treatment of osteoarticular infections in patients without renal dysfunction 99
Biliary pharmacodynamic exposure to linezolid in two liver transplant patients 98
Expert Opinion on Dose Regimen and Therapeutic Drug Monitoring for Long-Term Use of Dalbavancin: Expert Review Panel 92
Liposome-encapsulated daunorubicin for PGP-related multidrug resistance 92
Assessment of a pk/pd target of continuous infusion beta-lactams useful for preventing microbiological failure and/or resistance development in critically ill patients affected by documented gram-negative infections 92
Successful long-term treatment of cerebral nocardiosis with unexpectedly low doses of linezolid in an immunocompromised patient receiving complex polytherapy. 91
Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients. 91
A 5-year survey of antimicrobial susceptibility profiles of methicillin-resistant staphylococcus aureus (MRSA) isolated from patients with bloodstream infections in Northeast Italy 91
An Evidence-Based Multidisciplinary Approach Focused on Creating Algorithms for Targeted Therapy of Infection-Related Ventilator-Associated Complications (IVACs) Caused by Pseudomonas aeruginosa and Acinetobacter baumannii in Critically Ill Adult Patients 91
Is the use of vancomycin doses of at least 1 g every 8 hours the only way to achieve optimal trough levels in critically ill trauma patients with pneumonia and normal renal function? 90
Cerebrospinal fluid penetration of levofloxacin in patients with spontaneous acute bacterial meningitis 90
Hallucinations during voriconazole therapy: who is at higher risk and could benefit from therapeutic drug monitoring? 89
A descriptive case series of PK/PD target attainment and microbiological outcome in critically ill patients with documented severe XDR Acinetobacter baumannii BSI and/or VAP treated with cefiderocol 89
Long-term outcomes of orthotopic liver transplantation in human immunodeficiency virus-infected patients and comparison with human immunodeficiency virus-negative cases. 88
Comparison of the antibacterial activity and synergistic activity towards antibiotics of different mammalian sera 88
Italian guidelines for diagnosis, prevention, and treatment of invasive fungal infections in solid organ transplant recipients. 87
Blood concentrations and clinical effect of cyclosporin in psoriasis 87
Reply: Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis 86
A liquid chromatography-tandem mass spectrometry platform for the routine therapeutic drug monitoring of 14 antibiotics: Application to critically ill pediatric patients 86
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia 85
Population pharmacokinetics of dalbavancin and dosing consideration for optimal treatment of adult patients with staphylococcal osteoarticular infections 85
A Proof of Concept of the Role of TDM-Based Clinical Pharmacological Advices in Optimizing Antimicrobial Therapy on Real-Time in Different Paediatric Settings 85
Pharmacodynamics of antibiotics to treat multidrug-resistant Gram-positive hospital infections. 84
Might isoniazid plasma exposure be a valuable predictor of drug-related hepatotoxicity risk among adult patients with TB? 84
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 83
Targeted Therapy of Severe Infections Caused by Staphylococcus aureus in Critically Ill Adult Patients: A Multidisciplinary Proposal of Therapeutic Algorithms Based on Real-World Evidence 82
Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis 80
Candida endocarditis and the impact of antifungal treatment on the corrected QT interval: a case report 79
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam for treating DTR gram-negative infections in a case series of critically ill patients undergoing continuous veno-venous haemodiafiltration (CVVHDF) 78
Pharmacokinetics of two oral cyclosporin a formulations in clinically stable heart-transplant patients 78
Continuous versus intermittent infusion of antibiotics in Gram-negative multidrug-resistant infections 78
Gentamicin once-daily in enterococcal endocarditis 77
Dosing Nomograms for Attaining Optimum Concentrations of Meropenem by Continuous Infusion in Critically Ill Patients with Severe Gram-Negative Infections: a Pharmacokinetics/Pharmacodynamics-Based Approach 76
Actoxumab + bezlotoxumab combination: what promise for Clostridium difficile treatment? 76
Pharmacokinetics and pharmacodynamics of intravenous levofloxacin in patients with early-onset ventilator-associated pneumonia 74
Cyclosporine dose fractioning might affect renal function in stable heart transplanted patients 74
[PK/PD profile and post-marketing surveillance of levofloxacin] 72
Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6 72
Overview of antifungal dosing in invasive candidiasis 71
Liposome encapsulated daunorubicin (daunoxome) for acute leukemia 70
Systemic vancomycin overexposure in a patient with spinal cord injury who had staphylococcal sepsis and Clostridium difficile colitis 68
Successful Treatment of Bacteremia and Ventilator-Associated Pneumonia Caused by KPC/OXA-48-like Klebsiella pneumoniae Co-Producer with a Continuous Infusion of High-Dose Meropenem Plus Fosfomycin Guided by Real-Time Therapeutic Drug Monitoring 68
A multidrug resistant tuberculosis case treated with continuous infusion of meropenem in outpatient care 67
Pharmacokinetics and Pharmacodynamics of Continuous Infusion Meropenem in Overweight, Obese, and Morbidly Obese Patients with Stable and Unstable Kidney Function: A Step Toward Dose Optimization for the Treatment of Severe Gram-Negative Bacterial Infections 66
Pharmacokinetic profile of two different administration schemes of teicoplanin. Single 400 mg intravenous dose vs double-refracted 200 mg intramuscular doses in healthy volunteers 65
The clinical relevance of plasma protein binding changes 65
Multidrug resistance modulation in vivo: The effect of cyclosporin A alone or with dexverapamil on idarubicin pharmacokinetics in acute leukemia 65
Linezolid disposition after standard dosages in critically ill patients undergoing continuous venovenous hemofiltration: A report of 2 cases 64
Ceftobiprole: drug evaluation and place in therapy 63
The antimicrobial therapy puzzle: Could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients? 63
A descriptive case series of the relationship between maintenance of conservative PK/PD efficacy thresholds of dalbavancin over time and clinical outcome in long-term treatment of staphylococcal osteoarticular infections 62
General pharmacological considerations and dose adjustment in antibiotic therapy for HAP. 62
Antifungal prophylaxis with posaconazole in patients with acute myeloid leukemia: Dose intensification coupled with avoidance of proton pump inhibitors is beneficial in shortening time to effective concentrations 62
Real-Time Optimization of Pharmacodynamic Target Attainment at Infection Site during Treatment of Post-Neurosurgical Ventriculitis Caused by Carbapenem-Resistant Gram Negatives with Ceftazidime–Avibactam-Based Regimens: A Report of Two Cases 62
Reappraisal of linezolid dosing in renal impairment to improve safety 61
Assessment of the impact of clinical recommendations on antibiotic use for CAP and HCAP: results from an implementation program in an Academic Hospital 61
Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: Helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure 60
Therapeutic Drug Monitoring of Antifungal Drugs: Another Tool to Improve Patient Outcome? 60
Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis 60
Intracellular Pharmacokinetics of Antibacterials and Their Clinical Implications 59
Antimicrobial agents in elective surgery: prophylaxis or "early therapy"? 59
A Comparative Analysis of the Urinary Excretion Profiles of Mesna and Argimesna Following Oral Administration to Healthy Volunteers 59
Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxins 59
Levodopa and 3-O-methyldopa in cerebrospinal fluid after levodopa-carbidopa association 58
Antimicrobial treatment of bacterial infections in frail elderly patients: The difficult balance between efficacy, safety and tolerability 58
Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter? 58
Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP Inducers 58
Cyclosporin nephrotoxicity in relation to its metabolism in psoriasis 57
Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians? 57
Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia 57
Antimicrobial therapy in critically ill patients: A review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability 57
Co-administration of proton pump inhibitors and/or of steroids may be a risk factor for low trough concentrations of posaconazole delayed-released tablets in adult patients with haematological malignancies 57
Challenges in the management of chronic wound infections 57
Antiretroviral blood levels in HIV/HCV-coinfected patients with cirrhosis after liver transplant: A report of three cases 56
Sonidegib for the Treatment of Advanced Basal Cell Carcinoma 56
An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of bsis, cutis, and ciais caused by enterobacterales in critically ill adult patients 55
Impact of Maximizing Css/MIC Ratio on Efficacy of Continuous Infusion Meropenem Against Documented Gram-Negative Infections in Critically Ill Patients and Population Pharmacokinetic/Pharmacodynamic Analysis to Support Treatment Optimization 55
Usefulness of therapeutic drug monitoring in estimating the duration of dalbavancin optimal target attainment in staphylococcal osteoarticular infections: a proof-of-concept 54
Vancomycin way of administration: Where is the evidence? 53
Should the Clinical Pharmacologist Play a Role in the Multidisciplinary Team Managing Severe Necrotizing Soft-Tissue Infections? 53
A Response to: Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) 53
Totale 8.200
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.481
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.481
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020604 0 0 0 34 78 74 106 93 110 46 20 43
2020/20213.445 80 20 11 24 1.514 266 43 67 211 382 52 775
2021/20223.502 126 51 221 215 623 321 112 289 327 163 460 594
2022/20232.836 354 309 161 431 155 184 173 157 489 92 180 151
2023/20242.005 99 171 129 207 178 204 204 180 135 207 160 131
2024/20252.201 276 1.029 748 148 0 0 0 0 0 0 0 0
Totale 14.915